PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsLeft ventricular hypertrophy
MeSH D017379 - left ventricular hypertrophy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006332:Cardiomegaly
0 Companies
0 Drugs
Success rate
D017379: 
Left ventricular hypertrophy
$
Success rate
D000092183:Apical hypertrophic cardiomyopathy
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaLosartan potassium Losartan Potassium  2010-04-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-04-06   
MylanLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-04-06   
Lupin ResearchLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-05-21   
Chartwell PharmaceuticalsLosartan potassium Losartan Potassium  2010-10-06   
SandozHydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-08-19   
OrganonLosartan potassium Cozaar  1995-04-14   
Hydrochlorothiazide, Losartan potassium Hyzaar  1995-04-28   
Aurobindo PharmaLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-01-06   
Zydus TherapeuticsLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-10-06   
Alembic PharmaceuticalsLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2012-02-17   
ApotexLosartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2010-08-11   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/2
Phase 2
50%
3/6
Phase 3
41%
7/17
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use